Individual generic drug information

mometasone furoate

Reference monograph

Part of registered formulation

MOMETASONE FUROATE

Reference record: Mometasone furoate
Source: BNF 80 (2020–2021)
Printed source pages: 302
Age groups indexed: 2

Individual active ingredientSource records are displayed separately

Some source sections could not be separated reliably in the extraction. Review the printed source pages when a field is missing or incomplete.

Overview

Extracted information for Mometasone furoate only.

Indications And Dose

Prophylaxis of asthma ▶BY INHALATION OF POWDER ▶Child 12–17 years: Initially 400 micrograms daily in 1–2 divided doses, single dose to be inhaled in the evening, reduced to 200 micrograms once daily, if control maintained ▶Adult: Initially 400 micrograms daily in 1–2 divided doses, single dose to be inhaled in the evening, reduced to 200 micrograms once daily, if control maintained Prophylaxis of severe asthma ▶BY INHALATION OF POWDER ▶Child 12–17 years: Increased if necessary up to 400 micrograms twice daily ▶Adult: Increased if necessary up to 400 micrograms twice daily

Source page 302

National Funding Access Decisions

Scottish Medicines Consortium (SMC) decisions The Scottish Medicines Consortium has advised (November 2003) that Asmanex ® is restricted for use following failure of ﬁrst-line inhaled corticosteroids.

Source page 302

Safety

Extracted information for Mometasone furoate only.

Interactions

→Appendix 1: corticosteroids

Source page 302

Side Effects

▶Common or very common Candida infection

Source page 302

Dose and formulations

Extracted information for Mometasone furoate only.

Medicinal Forms

There can be variation in the licensing of different medicines containing the same drug. Inhalation powder CAUTIONARY AND ADVISORY LABELS 8, 10 ▶Asmanex Twisthaler (Merck Sharp & Dohme Ltd) Mometasone furoate 200 microgram per 1 dose Asmanex 200micrograms/dose Twisthaler | 30 dose P £15.70 DT = £15.70 | 60 dose P £23.54 DT = £23.54 Mometasone furoate 400 microgram per 1 dose Asmanex 400micrograms/dose Twisthaler | 30 dose P £21.78 DT = £21.78 | 60 dose P £36.05 DT = £36.05 ENZYME INHIBITORS

Source page 302

Clinical care

Extracted information for Mometasone furoate only.

Patient And Carer Advice

Medicines for Children leaflet: Mometasone furoate inhaler for asthma prevention (prophylaxis) www.medicinesforchildren.org. uk/mometasone-furoate-inhaler-asthma-prevention- prophylaxis Patients or carers should be given advice on how to administer mometasone by inhaler. With high doses, a steroid card should be supplied.

Source page 302

Dose text by age group

Filter the extracted dose blocks for this individual drug.

Children

First line only; read the complete Indications and dose section above.

Initially 400 micrograms daily in

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 302

Adults

First line only; read the complete Indications and dose section above.

Initially 400 micrograms daily in 1–2 divided

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 302

Children

First line only; read the complete Indications and dose section above.

Increased if necessary up to

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 302

Adults

First line only; read the complete Indications and dose section above.

Increased if necessary up to 400 micrograms

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 302

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.

Individual generic drug information

mometasone furoate

Reference monograph

Part of registered formulation

MOMETASONE FUROATE

Reference record: Mometasone furoate
Source: BNF 80 (2020–2021)
Printed source pages: 302
Age groups indexed: 2

Individual active ingredientSource records are displayed separately

Some source sections could not be separated reliably in the extraction. Review the printed source pages when a field is missing or incomplete.

Overview

Extracted information for Mometasone furoate only.

Indications And Dose

Source page 302

National Funding Access Decisions

Source page 302

Safety

Extracted information for Mometasone furoate only.

Interactions

→Appendix 1: corticosteroids

Source page 302

Side Effects

▶Common or very common Candida infection

Source page 302

Dose and formulations

Extracted information for Mometasone furoate only.

Medicinal Forms

Source page 302

Clinical care

Extracted information for Mometasone furoate only.

Patient And Carer Advice

Source page 302

Dose text by age group

Filter the extracted dose blocks for this individual drug.

Children

First line only; read the complete Indications and dose section above.

Initially 400 micrograms daily in

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 302

Adults

First line only; read the complete Indications and dose section above.

Initially 400 micrograms daily in 1–2 divided

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 302

Children

First line only; read the complete Indications and dose section above.

Increased if necessary up to

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 302

Adults

First line only; read the complete Indications and dose section above.

Increased if necessary up to 400 micrograms

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 302

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.